Soligenix (SNGX) Has Busy Calendar Ahead

Soligenix Inc. (SNGX), a late-stage biopharmaceutical company developing products to treat rare diseases, has multiple potential value drivers, making the stock worth watching.

from RTT - Biotech https://ift.tt/2SWIC21
via IFTTT